Association between proximal stent edge positioning on atherosclerotic plaques containing lipid pools and

Fabrizio Imola1, Michele Occhipinti, Giuseppe Biondi-Zoccai

  • 1Interventional Cardiology, San Giovanni Hospital, Rome, Italy.

Insights

Stenting over coronary lipid pools during percutaneous coronary intervention (PCI) increases the risk of postprocedural myocardial infarction. Optical coherence tomography (OCT) revealed incomplete stent coverage of lipid pools is linked to adverse outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Imaging

Background:

  • Postprocedural myocardial infarction is a serious complication of percutaneous coronary intervention (PCI).
  • The impact of stent placement on coronary lipid pools, visualized by optical coherence tomography (OCT), on patient outcomes remains unclear.

Purpose of the Study:

  • To investigate the association between postprocedural myocardial infarction and stent edge placement on coronary lipid pools, as assessed by OCT.
  • To determine if incomplete stent coverage of lipid pools influences adverse cardiac events after PCI.

Main Methods:

  • Retrospective analysis of patients undergoing PCI with stenting for de novo coronary lesions.
  • Optical coherence tomography (OCT) was used for post-PCI imaging and plaque characterization, quantifying lipid pools at stent edges.
  • Patients with postprocedural myocardial infarction were matched 1:1 with controls without myocardial infarction.

Main Results:

  • Landing proximal stent edges on lipid pools was significantly more frequent in patients with postprocedural myocardial infarction (66%) compared to controls (13%).
  • Patients experiencing myocardial infarction had more extensive lipid pools at proximal stent edges.
  • Lipid pool arc at the proximal stent edge correlated significantly with elevated cardiac enzyme levels (creatine kinase-MB).

Conclusions:

  • Incomplete stent coverage of coronary lipid pools is associated with an increased risk of postprocedural myocardial infarction.
  • OCT assessment of lipid pools at stent edges may help identify patients at higher risk for adverse events after PCI.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...